Author
Listed:
- Takuya Kuroda
(Division of Cell-Based Therapeutic Products, National Institute of Health Sciences)
- Satoshi Yasuda
(Division of Cell-Based Therapeutic Products, National Institute of Health Sciences)
- Shiori Tachi
(Division of Cell-Based Therapeutic Products, National Institute of Health Sciences
Nagoya City University)
- Satoko Matsuyama
(Division of Cell-Based Therapeutic Products, National Institute of Health Sciences
Fujita Health University)
- Shinji Kusakawa
(Division of Cell-Based Therapeutic Products, National Institute of Health Sciences)
- Keiko Tano
(Division of Cell-Based Therapeutic Products, National Institute of Health Sciences)
- Takumi Miura
(Division of Cell-Based Therapeutic Products, National Institute of Health Sciences)
- Akifumi Matsuyama
(Fujita Health University)
- Yoji Sato
(Division of Cell-Based Therapeutic Products, National Institute of Health Sciences
Nagoya City University
Osaka University
Kyushu University)
Abstract
Clinical applications of human induced pluripotent stem cells (hiPSCs) are expected, but hiPSC lines vary in their differentiation propensity. For efficient selection of hiPSC lines suitable for differentiation into desired cell lineages, here we identify SALL3 as a marker to predict differentiation propensity. SALL3 expression in hiPSCs correlates positively with ectoderm differentiation capacity and negatively with mesoderm/endoderm differentiation capacity. Without affecting self-renewal of hiPSCs, SALL3 knockdown inhibits ectoderm differentiation and conversely enhances mesodermal/endodermal differentiation. Similarly, loss- and gain-of-function studies reveal that SALL3 inversely regulates the differentiation of hiPSCs into cardiomyocytes and neural cells. Mechanistically, SALL3 modulates DNMT3B function and DNA methyltransferase activity, and influences gene body methylation of Wnt signaling-related genes in hiPSCs. These findings suggest that SALL3 switches the differentiation propensity of hiPSCs toward distinct cell lineages by changing the epigenetic profile and serves as a marker for evaluating the hiPSC differentiation propensity.
Suggested Citation
Takuya Kuroda & Satoshi Yasuda & Shiori Tachi & Satoko Matsuyama & Shinji Kusakawa & Keiko Tano & Takumi Miura & Akifumi Matsuyama & Yoji Sato, 2019.
"SALL3 expression balance underlies lineage biases in human induced pluripotent stem cell differentiation,"
Nature Communications, Nature, vol. 10(1), pages 1-13, December.
Handle:
RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-09511-4
DOI: 10.1038/s41467-019-09511-4
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-09511-4. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.